Urs J Muehlematter
Impact of Ga-PSMA-11 PET staging on clinical decision-making in patients with intermediate or high-risk prostate cancer
Ferraro D, Hermanns T, Kaufmann P, Omlin A, Kranzbühler H, Gablinger R, Müller A, Müller J, Eberli D, Muehlematter U, Garcia Schüler H, Burger I. Impact of Ga-PSMA-11 PET staging on clinical decision-making in patients with intermediate or high-risk prostate cancer. Eur J Nucl Med Mol Imaging 2019
Dec 4, 2019Impact of Ga-PSMA-11 PET staging on clinical decision-making in patients with intermediate or high-risk prostate cancer
Dec 4, 2019Eur J Nucl Med Mol Imaging 2019
Ferraro Daniela A, Hermanns Thomas, Kaufmann Philipp A, Omlin Aurelius, Kranzbühler Helmut, Gablinger Roger, Müller Alexander, Müller Julian, Eberli Daniel, Muehlematter Urs J, Garcia Schüler Helena I, Burger Irene A
Clinical impact of Ga-PSMA-11 PET on patient management and outcome, including all patients referred for an increase in PSA level during the first year after its clinical introduction
Müller J, von Schulthess G, Kaufmann P, Kranzbuehler H, John H, Zilli T, Müller A, Omlin A, Schmid D, Sulser T, Kroeze S, Guckenberger M, Eberli D, Kedzia S, Garcia Schüler H, Muehlematter U, Ferraro D, Burger I. Clinical impact of Ga-PSMA-11 PET on patient management and outcome, including all patients referred for an increase in PSA level during the first year after its clinical introduction. Eur J Nucl Med Mol Imaging 2018
Nov 28, 2018Clinical impact of Ga-PSMA-11 PET on patient management and outcome, including all patients referred for an increase in PSA level during the first year after its clinical introduction
Nov 28, 2018Eur J Nucl Med Mol Imaging 2018
Müller Julian, von Schulthess Gustav K, Kaufmann Philipp A, Kranzbuehler Helmut, John Hubert, Zilli Thomas, Müller Alexander, Omlin Aurelius, Schmid Daniel M, Sulser Tullio, Kroeze Stephanie G C, Guckenberger Matthias, Eberli Daniel, Kedzia Sarah, Garcia Schüler Helena I, Muehlematter Urs J, Ferraro Daniela A, Burger Irene A
Value of PET/MRI for assessing tumor resectability in NSCLC - intra-individual comparison with PET/CT
Messerli M, Frauenfelder T, Huellner M, Ter Voert E, Delso G, Warschkow R, Stolzmann P, Muehlematter U, Marcon M, Barbosa F, Veit-Heibach P. Value of PET/MRI for assessing tumor resectability in NSCLC - intra-individual comparison with PET/CT. Br J Radiol 2018:20180379.
Sep 13, 2018Value of PET/MRI for assessing tumor resectability in NSCLC - intra-individual comparison with PET/CT
Sep 13, 2018Br J Radiol 2018:20180379
Messerli Michael, Frauenfelder Thomas, Huellner Martin W, Ter Voert Edwin Egw, Delso Gaspar, Warschkow Rene, Stolzmann Paul, Muehlematter Urs J, Marcon Magda, Barbosa Felipe, Veit-Heibach Patrick